Introduction to Gamma Knife Radiosurgery Training Course

Miami, FL US
December 5, 2022 to December 8, 2022

The Miami Cancer Institute Department of Radiation Oncology and the Florida International University Herbert Wertheim College of Medicine are pleased to present this Introduction to Gamma Knife® Radiosurgery Training Course for radiation oncologists, neurosurgeons, medical physicists, neuro-otolaryngologists, and other healthcare professionals interested in Gamma Knife radiosurgery training.

This educational program provides an opportunity to enhance the practitioner’s knowledge about the practical aspects of stereotactic radiosurgery using the Gamma Knife IconTM. Participants will review clinical implications and clinical outcomes of radiosurgery, identify radiation safety principals, and apply treatment planning considerations and principals of stereotactic radiosurgery treatment hardware. As part of Miami Cancer Institute’s internationally recognized radiation oncology program, our team of experts offers a non-surgical radiation treatment called Gamma Knife radiosurgery – the most modern technology available – in South Florida’s only state-of-the-art Icon Gamma Knife Center.

Target Audience

Neurosurgeons, medical physicists, radiation oncologists and neuro-otolaryngologists.

Authorized Training Participants (Trainees) are limited to individuals from institutions that have already purchased the Gamma Knife Icon™.  These sessions are not open to individuals from institutions that are prospective customers who seek training prior to purchasing the Gamma Knife Icon™.  

Learning Objectives

  • Recognize the basic principles and physics of radiosurgery and how they relate to day-to-day patient treatment.
  • Review the clinical implications, treatment parameters and clinical outcomes of radiosurgery.
  • Identify radiation safety principles and potential issues of radiosurgery and review emergency procedures.
  • Apply principles of stereotactic frame and mask application, imaging and radiosurgery treatment hardware. ​
Course Summary
Available credit: 
  • 31.25 AMA PRA Category 1 Credit™
  • 31.25 General certificate of attendance
Course opens: 
02/07/2022
Course expires: 
12/30/2022
Event starts: 
12/05/2022 - 8:00am EST
Event ends: 
12/08/2022 - 5:00pm EST
Cost:
$6,500.00
Miami Cancer institute
8900 N. Kendall Dr
In person
Miami, FL 33176
United States

Course Directors

Rupesh Kotecha, M.D.
Chief of Radiosurgery, Director of CNS Metastasis, Department of Radiation Oncology
Miami Cancer Institute, Baptist Health South Florida
Associate Professor, Department of Radiation Oncology
Herbert Wertheim College of Medicine, Florida International University
RupeshK@BaptistHealth.net

Minesh P. Mehta, M.D.
Deputy Director and Chief of Radiation Oncology, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida
Chair and Professor, Department of Radiation Oncology
Herbert Wertheim College of Medicine, Florida International University
MineshM@BaptistHealth.net

Michael W. McDermott, M.D.
Chief Medical Executive, Miami Neuroscience Institute
Professor of Neurosurgery, Chair, Division of Neuroscience
Herbert Wertheim College of Medicine, Florida International University
MWMCD@BaptistHealth.net

Program Coordinator

Shandelle M. Castillo, MHA
Radiation Oncology Program Coordinator

Faculty

Kevin J. Abrams, M.D.
Medical Director of Neuroradiology and MRI, Chief of Radiology, Baptist Hospital of Miami

Haley R. Appel, PA-C, MMS
Physician Assistant, Miami Cancer Institute

Denise C. Aponte, RT(T)
Radiation Therapist Auditor, Miami Cancer Institute

Michael D. Chuong, M.D., FACRO
Director of Proton Therapy, Director of MR-Guided Radiation Therapy, Director of Radiation Oncology Clinical Research, Miami Cancer Institute

Alonso N. Gutierrez, Ph.D., MBA
Assistant Vice President, Chief Physicist, Miami Cancer Institute

Matthew D. Hall, M.D., MBA
Lead Pediatric Radiation Oncologist, Director of Live Like Bella® Pediatric Radiation Oncology Program, Miami Cancer Institute

Susan E. Lohman, R.N., BSN
Manager, RNCA Neuroscience Applications, Elekta

Clare Morales, RN, BSN
Expert Nurse, Miami Cancer Institute

Toba Niazi, MD
Pediatric Neurosurgeon, Director of Neuro-Oncology Program, Nicklaus Children’s Hospital

Yazmin Odia, MD, MS, FAAN
Chief of Neuro-Oncology, Miami Cancer Institute

Vitaly Siomin, MD, FAANS
Medical Director of Brain Tumor Program, Miami Neuroscience Institute

Ranjini Tolakanahalli, PhD, DABR
Senior Physicist, Miami Cancer Institute

D Jay Wieczorek, PhD
Senior Physicist, Miami Cancer Institute

Relevant Financial Relationships

The following individuals involved in the planning, development, review, presentation, authoring and/or editing of the course content have disclosed relevant financial relationships with commercial interest companies, and the CME Department has resolved these potential conflicts of interest. Their presentation(s) will not include discussion of off-label or unapproved usage.

Kevin J. Abrams, M.D., is a consultant for Keystone Heart and Viz Ai and a stock shareholder for Keystone Heart, Cleerly and Viz Ai. He is an employee for Radiology Partners - Radiology Associates of South Florida.

Manmeet Ahluwalia, M.D. has received grant/research support from Abbvie, Roswell Park, Astra-Zeneca, Bayer, BMS, Incyte, Merck, Mimivax, Novartis, Novocure, Pharmacyclics and Velosano.  He is a consultant with BMS, Novocure, Celularity, Elsevier, insightec, Kiyatec, Novocure and Xoft.  He is a stockholder with Mimivax, Cytodyn, Doctible and MedInnovate Advisors, LLC. 

Haley R. Appel, PA-C, MMS, is a consultant with Novocure.

Carolina G. Benjamin, M.D., is a consultant with Medtronic and Stryker.  Dr. Benjamin is also a speaker with Elekta.  

Michael D. Chuong, M.D., FACRO, has received grant/research support from ViewRay, Inc., Novocure and StrathPharma.  He is also a speaker with ViewRay, Sirtex, Elekta and IBA.

Alonso N. Gutierrez, Ph.D., MBA is a speaker with IBA, ViewRay, Accuray and Elekta. 

Rupesh Kotecha, M.D., has received honorariums from Elekta, Elsevier, ViewRay, Novocure, Brainlab and Accuray, Inc., and serves on the Clinical Advisory Boards for Accuray, Inc. and Novocure. He has received research support from Medtronic, B Earth Diagnostics, Novocure, Exelixis, Astrazeneca, Viewray and Brainlab.

Susan Lohman, R.N., BSN, is an employee of Elekta.

Michael W. McDermott, M.D., is a consultant for Deinde Medical, Stryker and ZAP Surgical.

Minesh P. Mehta, M.D., FASTRO, is on the Board of Directors for Oncoceutics, serves on the Medical Advisory Board for Mevion and is a consultant for Karyopharm, Sapience and Xoft and is a stock/shareholder with Chimerix.

Yazmin Odia, M.D., M.S., FAAN, has received research support from Novocure – trial support BMS, is a consultant with Istari Oncology, Inc., and on the scientific safety monitoring board with Gammatile GT. 

Nothing to Disclose

The following individuals involved in the planning, development, review, presentation, authoring and/or editing of the course content have indicated that neither they nor their spouses/partners have relevant financial relationships with commercial interest companies. Their presentation(s) will not include discussion of off-label or unapproved usage.

  • Denise Aponte, RT(T)
  • Matthew D. Hall, M.D., MBA
  • Clare Morales, R.N., BSN
  • Toba Niazi, MD 
  • Vitaly Siomin, M.D.
  • Ranjini Tolakanahalli, Ph.D., DABR
  • D. Jay Wieczorek, Ph.D.

Non-faculty contributors including the CME Department staff and CME Committee members and others involved in the planning, development and editing/review of CME content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Baptist Health South Florida designates this live activity for a maximum of 30.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for a maximum of 30 Medical Physics Continuing Education Credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Program (CAMPEP).

Available Credit

  • 31.25 AMA PRA Category 1 Credit™
  • 31.25 General certificate of attendance

Price

Cost:
$6,500.00
Please login or register to take this course.

COVID Protocol - Proof of Vaccination will be required when attending in-person.

ELIGIBILITY:  Participants are limited to individuals from institutions that have already purchased a Gamma Knife™.  These sessions are not open to individuals from institutions that are prospective customers who seek training prior to purchasing a Gamma Knife™. You will be asked to provide your institution affiliation during the registration process. 

Registration options for eligible participants are based on prior training. 
Eligible Participants with NO PRIOR TRAINING: Obtain a Registration Code by contacting  Nikki Mejia, Research Program Administrative Assistant, at NikkiM@baptisthealth.net or 786-527-7909. After you receive your registration code, please proceed with the registration process through the link just below. 
Eligible Participants WITH PRIOR TRAINING: Please proceed with the registration process through the link below. 
*If paying by check: Register now to reserve your place in the course.

Checks should be made payable to:
Baptist Health South Florida
ATTN: CME Dept/Gamma Knife
8900 N. Kendall Dr.
Miami, FL 33176

Payment must be received no later than 30 days prior to the start date of the course. Payment instructions will be emailed to you after you complete online enrollment.

Required Hardware/Software

If you are only seeing this message, please look in the upper right hand and see if there is something in your shopping cart.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support